Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 2
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Predictors of Unfavorable Pathology in Patients with Incidental (pT1a-T1b) Prostate Cancer.
Tsaur I, van den Bergh RCN, Soeterik T, Thomas A, Brandt MP, Zattoni F, Dal Moro F, Morlacco A, Collavino J, Ploussard G, Surcel C, Mirvald C, Carmona O, Rosenzweig B, Ruckes C, Heisinger T, Heidegger I, Gandaglia G, Dotzauer R; European Association of Urology Young Academic Urologists Prostate Cancer Working Party. Tsaur I, et al. Eur Urol Focus. 2022 Nov;8(6):1599-1606. doi: 10.1016/j.euf.2022.03.009. Epub 2022 Mar 19. Eur Urol Focus. 2022. PMID: 35317972
Metastatic Sites' Location and Impact on Patient Management After the Introduction of Prostate-specific Membrane Antigen Positron Emission Tomography in Newly Diagnosed and Biochemically Recurrent Prostate Cancer: A Critical Review.
Mattana F, Muraglia L, Rajwa P, Zattoni F, Marra G, Chiu PKF, Heidegger I, Kasivisvanathan V, Kesch CV, Olivier J, Preisser F, Thibault C, Valerio M, van den Bergh RCN, Gandaglia G, Ceci F; European Association of Urology Young Academic Urologists Prostate Cancer Working Party. Mattana F, et al. Eur Urol Oncol. 2023 Apr;6(2):128-136. doi: 10.1016/j.euo.2023.01.014. Epub 2023 Feb 16. Eur Urol Oncol. 2023. PMID: 36804735 Free article. Review.
Intensification of Systemic Therapy in Addition to Definitive Local Treatment in Nonmetastatic Unfavourable Prostate Cancer: A Systematic Review and Meta-analysis.
Rajwa P, Pradere B, Gandaglia G, van den Bergh RCN, Tsaur I, Shim SR, Yanagisawa T, Laukhtina E, Mori K, Mostafaei H, Quhal F, Bryniarski P, Compérat E, Roubaud G, Massard C, Merseburger AS, Leapman MS, Spratt DE, Saad F, Joniau S, D'Amico AV, Briganti A, Shariat SF, Ploussard G; European Association of Urology Young Academic Urologists Prostate Cancer Working Party. Rajwa P, et al. Eur Urol. 2022 Jul;82(1):82-96. doi: 10.1016/j.eururo.2022.03.031. Epub 2022 Apr 22. Eur Urol. 2022. PMID: 35465985 Free article. Review.
External validation of nomograms including MRI features for the prediction of side-specific extraprostatic extension.
Heetman JG, van der Hoeven EJRJ, Rajwa P, Zattoni F, Kesch C, Shariat S, Dal Moro F, Novara G, La Bombara G, Sattin F, von Ostau N, Pötsch N, Baltzer PAT, Wever L, Van Basten JPA, Van Melick HHE, Van den Bergh RCN, Gandaglia G, Soeterik TFW; European Association of Urology Young Academic Urologists Prostate Cancer Working Party. Heetman JG, et al. Prostate Cancer Prostatic Dis. 2023 Nov 6. doi: 10.1038/s41391-023-00738-3. Online ahead of print. Prostate Cancer Prostatic Dis. 2023. PMID: 37932522
METHODS: Data of prostate cancer (PCa) patients that underwent robot-assisted RP (RARP) from 2017 to 2021 at four European tertiary referral centers were collected retrospectively. ...The Nyarangi-Dix nomogram demonstrated a higher net benefit for risk thresholds between 2 …
METHODS: Data of prostate cancer (PCa) patients that underwent robot-assisted RP (RARP) from 2017 to 2021 at four European tertiary r …